For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...

Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...

A HIGHLY contagious Victorian disease that has seen UK cases soar is silently spreading because of a lack of understanding over what it is, experts have warned. Leading dermatologists said people ...

Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of ...

A lack of understanding about what scabies is and how it’s treated could be behind the United Kingdom’s sudden spike in cases ...

Corvus Pharmaceuticals soared by 211.8 percent week-on-week to hit a new all-time high, as investors cheered the strong ...

Jia Patrick told Newsweek that living with TSW has been "a truly harrowing experience" that will take a long time to recover ...

Sanofi recently reported late-stage trial results showing its experimental eczema drug amlitelimab met key endpoints in ...

Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

Corvus Pharmaceuticals extended its winning streak to a 6th straight session on Thursday to hit a new all-time high, as ...

Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...